- PILL Stock Page
ProxyMed Inc. (NASDAQ:PILL)
Last Update: Jul 31 at 3:58 ET
| Change: | 0.00 (0.00%) |
| Last Trade: | 0.04 |
| Prev Close: | 0.04 |
| Share Volume: | N/A |
| Market Cap: | 551.32K |
| EPS (Earnings per share): | -1.45 |
| P/E (Price/earning ratio): | N/A |
| P/B (Price/book ratio): | N/A |
| Stock Price History | |
|---|---|
| Beta: | -0.00 |
| 52 week change: | -98.60% |
| 52 week high: | 3.14 |
| 52 week low: | 0.03 |
| 50 day moving avarage: | 0.13 |
| 200 day moving avarage: | 0.87 |
| Dividends | |
| Ex dividend date: | N/A |
| Dividend yield: | N/A |
| Dividend rate: | N/A |
| Share Statistics | |
| Avarage 10 day volume: | 681,503 |
| Shares outstanding: | 13,782,915 |
| Short interest date: | Jul 10, 2008 |
| Short shares: | 524,401 |
| Short ratio: | 21.60 |
| Short % of float: | 4.00% |
| Today | 5d | 1m | 3m | 6m | 1y | 5y |
Latest Headlines for PILL
-
Jul 29 at 4:43 ET
MedAvant Announces Receipt of NASDAQ Notice of Delisting
Company Profile
Sector: Technology
Industry: Computer Software & Services
healthcare information services
An information technology company that facilitates the exchange of medical claim and clinical information among doctors, hospitals, medical laboratories, pharmacies and insurance payers.
PILL Headlines
-
Jul 29 at 4:43 ET
MedAvant Announces Receipt of NASDAQ Notice of Delisting -
Jul 24 at 3:49 ET
MedAvant Wins Interim Approval From Bankruptcy Court for $2.9 Million in New Financing to Support Ordinary Course of Business in Chapter 11 -
Jul 23 at 12:16 ET
MedAvant Announces Voluntary Reorganization Filing, Debtor-In-Possession Financing, and Stalking Horse Bid -
Jul 22 at 5:37 ET
Medavant Announces Receipt of Notice of Non-Compliance From Nasdaq -
Jul 02 at 11:49 ET
MedAvant Closes Sale of Its Lab Services Business to ETSec -
May 23 at 8:10 ET
MedAvant Announces Agreement to Sell Lab Services Business to ETSec -
May 20 at 8:38 ET
MedAvant Announces First Quarter 2008 Results -
May 15 at 5:55 ET
MedAvant to Extend 10-Q Filing Date and Files for Extension -
Apr 28 at 5:33 ET
MedAvant Announces Notice of Non-Compliance from Nasdaq -
Apr 22 at 7:03 ET
MedAvant Announces Receipt of Going Concern Opinion